Altimmune, Inc. Common Stock ALT
i
Market datapartial · fetched 2026-11-10T22:17:48.226Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-13
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-10T22:06:33.64900338Z
FundamentalsAlpha Vantage · unavailable
Altimmune, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 1.56 | 299.2% | 22.9% | |||
| 25Δ | 1.62 | 273.9% | 20.3% | |||
| 30Δ | 1.67 | 248.6% | 17.7% | |||
| 35Δ | 2.35 | 252.9% | 25.2% | 1.73 | 223.4% | 15.1% |
| 40Δ | 2.22 | 236.3% | 19.2% | 1.79 | 198.1% | 12.4% |
| 45Δ | 2.09 | 219.6% | 13.2% | 1.84 | 172.8% | 9.8% |
| 50Δ | 1.98 | 215.8% | 8.7% | |||
| 55Δ | 1.90 | 241.4% | 8.0% | |||
| 60Δ | 1.83 | 267.0% | 7.2% | |||
| 65Δ | 1.76 | 292.6% | 6.5% | |||
| 70Δ | 1.68 | 318.2% | 5.7% | 3.04 | 617.3% | 8.3% |
| 75Δ | 1.61 | 343.7% | 5.0% | |||
| 80Δ | 1.54 | 369.3% | 4.2% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.56
- IV
- 299.2%
- B/E move
- 22.9%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.62
- IV
- 273.9%
- B/E move
- 20.3%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.67
- IV
- 248.6%
- B/E move
- 17.7%
35Δ
- Pseudo strike
- 2.35
- IV
- 252.9%
- B/E move
- 25.2%
- Pseudo strike
- 1.73
- IV
- 223.4%
- B/E move
- 15.1%
40Δ
- Pseudo strike
- 2.22
- IV
- 236.3%
- B/E move
- 19.2%
- Pseudo strike
- 1.79
- IV
- 198.1%
- B/E move
- 12.4%
45Δ
- Pseudo strike
- 2.09
- IV
- 219.6%
- B/E move
- 13.2%
- Pseudo strike
- 1.84
- IV
- 172.8%
- B/E move
- 9.8%
50Δ
- Pseudo strike
- 1.98
- IV
- 215.8%
- B/E move
- 8.7%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 1.90
- IV
- 241.4%
- B/E move
- 8.0%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 1.83
- IV
- 267.0%
- B/E move
- 7.2%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 1.76
- IV
- 292.6%
- B/E move
- 6.5%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 1.68
- IV
- 318.2%
- B/E move
- 5.7%
- Pseudo strike
- 3.04
- IV
- 617.3%
- B/E move
- 8.3%
75Δ
- Pseudo strike
- 1.61
- IV
- 343.7%
- B/E move
- 5.0%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 1.54
- IV
- 369.3%
- B/E move
- 4.2%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 136.80% | |
| 94.19% | |
| 338.01% | |
| 257.20% | |
| 366.04% | |
| 333.88% | |
| 259.06% | |
| 267.21% | |
| 435.56% | |
| 529.74% | |
| 328.23% | |
| 424.16% |
Biotechnology
ALXO
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. The company is headquartered in Burlingame,…
More →ANAB
AnaptysBio, Inc., a clinical-stage biotechnology company, is dedicated to developing therapeutic product candidates for inflammation and immuno-oncology indications. The company…
More →ANIX
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is…
More →ANNX
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for autoimmune and neurodegenerative diseases. The company is headquartered in South…
More →ANRO
Description unavailable
More →ANTX
Anthem, Inc., is a health benefits company in the United States. The company is headquartered in Indianapolis, Indiana.
More →